In this review, studies focusing on the therapeutic use of psychedelics for treating mental health disorders published since 2010 have been examined. A systematic literature search was conducted using Medline and EBSCO. After extracting data from 19 papers, an analysis was performed. Critical evidence highlighting the effectiveness of psychedelic drugs in treating depression, anxiety,...
Major depressive disorder (MDD) is a debilitating illness with a high global burden. While Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, offers rapid-acting antidepressant effects, its mechanism remains incompletely understood. Recent research suggests that dysregulation of mRNA translation via the Eukaryotic initiation factor 4E (eIF4E) pathway might contribute to depression...
Research has shown that 20% of Czech teachers suffer with burnout symptoms and 65% are at risk of burning out, which suggests that it is essential to continue addressing the issue of stress in Czech teachers. The main objective of this study was to evaluate a self-compassion and mindfulness-based professional development program for primary school teachers in the Czech Republic. Five schools...
This article presents a critical reinterpretation of the concept of "drugs" in contemporary society, challenging the traditional categorization that separates legal substances from illegal ones. Through a multidisciplinary analysis incorporating psychology, neuroscience, and sociology, it argues that drugs, regardless of their legal status, are merely stimulatory substances that serve as...
Introduction: Psilocybin, a classical psychedelic, has been rescheduled for use in psilocybin-assisted psychotherapy for treatment-resistant depression in Australia. While evidence for its use is promising, understanding the associated risks is crucial. Accordingly, this review aims to collate adverse event data from psilocybin-assisted psychotherapy clinical trials and evaluate its definition,...
Background: Meditation practices are currently being incorporated in psychotherapeutic interventions to address globally increasing rates of psychopathology. Meditation has been a common practice in Sri Lanka since early times. However, the integration of meditation as practiced in a Sri Lankan context, into psychotherapeutic interventions require rigorous empirical exploration. Objectives: The...
Abstract This study examines the impact of adding and incorporating a meditation practice into a treatment plan for Posttraumatic Stress Disorder (PTSD) for three adult patients at a Federally Qualified Health Center (FQHC). The cases involved included patients with persistent PTSD symptoms who had experienced limited improvement with standard therapies. Data from Electronic Health Records and...
Purpose: The goal of this case report is to illustrate the implementation of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder (PTSD) and learning points for health professionals in the translation of psychedelic assisted therapy research into clinical practice. We present our key learnings and 6-month follow up data from one of the first patients to...
Background Using [ 18 F]altanserin, a serotonin 2A receptor (5-HT 2A R) antagonist Positron Emission Tomography (PET) tracer, a positive association between cortical 5-HT 2A R binding and the inward-directed facets of neuroticism has been demonstrated in healthy individuals. Psilocybin, a 5-HT 2A R agonist, shows promise for the treatment of depression, reducing neuroticism and mood symptoms...
PharmaceuticalsDecember 4, 2024Andrea Macejova, Veronika Kovacova, Ingrid Tonhajzerova et al.7 citations
Background: Adolescent treatment resistant depression (TRD) is increasing in recent years. While ketamine showed rapid antidepressant effects in adult TRD studies, research on its effectiveness in adolescents is limited. Methods: This study examines the effects of intravenous ketamine vs. midazolam on depressive and anxiety symptomatology assessed by the Montgomery-Åsberg Depression Rating...